InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (5 ops.)
Explore the complete record of transactions filed by Hallal David, Director. Officer active across 3 companies, notably iTeos Therapeutics, Inc.. In total, 9 filings have been logged. Total volume traded: €765k. The latest transaction was disclosed on 15 June 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations9 total
09,945 shares0
Class A Common Stock
SEC:0001209191-22-038097:0·
€23,5545,968 shares@ €3.946813.3% of flow
Common Stock
SEC:0001209191-22-036137:0·
€224,26265,725 shares@ €3.412129.3% of flow
Common Stock
SEC:0000899243-22-021183:0·
€22,9004,227 shares@ €5.41753.0% of flow
Common Stock
SEC:0000899243-22-015395:0·
€276,13040,481 shares@ €6.821236.1% of flow
Common Stock
SEC:0000899243-22-010762:0·
€120,69817,100 shares@ €7.058315.8% of flow
Common Stock
SEC:0000899243-22-003144:0·
€120,69817,100 shares@ €7.0583100.0% of flow
Common Stock
SEC:0000899243-22-003144·
€76,48820,000 shares@ €3.8244100.0% of flow
Common Stock
SEC:0001209191-21-070993·
€76,48820,000 shares@ €3.824443.3% of flow
Common Stock
SEC:0001209191-21-070993:0·
9 of 9 declarations
About Hallal David
David Hallal serves as a Director at iTeos Therapeutics, Inc., Allovir, Inc., and Seer, Inc. He brings significant expertise in the biopharmaceutical sector. His experience allows him to contribute effectively to strategic discussions and decision-making within the boards. David is recognized for his ability to assess market opportunities and formulate informed recommendations for the company's development.
